Skip to content
Wenlo
Sign in
← Markets

United Therapeutics Corporation

Martine A Rothblatt (Chairperson & CEO) sells UTHR shares

4UTHRFiled Nov 5, 2026, 5:21 PM ET· Period Nov 4, 2026

AI-generated summary

Chairperson & CEO, Director Martine A Rothblatt sold 1,723 shares of common stock for an average price of $611.06, totaling $1,052,853.99, indirectly by Trust. After these transactions, 324,443 shares were held indirectly by Trust. These sales were made under a Rule 10b5-1 trading plan adopted on November 7, 2025.

View original filing on SEC.gov (opens SEC EDGAR)

Key facts

Insider
Martine A Rothblatt · Chairperson & CEO, Director

Rule 10b5-1 plan · adopted Nov 7, 2025

DateTransactionSharesPriceValueHeld afterOwnership
Nov 4, 2026S · open-market saleFootnotes F1, F2, F3−842$610.29$513,866.54325,324Indirect (by Trust)
Nov 4, 2026S · open-market saleFootnotes F1, F4, F3−403$611.26$246,336.61324,921Indirect (by Trust)
Nov 4, 2026S · open-market saleFootnotes F1, F5, F3−398$612.06$243,600.04324,523Indirect (by Trust)
Nov 4, 2026S · open-market saleFootnotes F1, F6, F3−80$613.13$49,050.80324,443Indirect (by Trust)
Footnotes
  1. F1 This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
  2. F2 This transaction was executed in multiple trades at prices ranging from $609.78 to $610.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. F3 Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
  4. F4 This transaction was executed in multiple trades at prices ranging from $610.79 to $611.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. F5 This transaction was executed in multiple trades at prices ranging from $611.87 to $612.39. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  6. F6 This transaction was executed in multiple trades at prices ranging from $613.12 to $613.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  7. F7 Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
  8. F8 Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
  9. F9 Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.

Remarks: Due to the 30 line limitation in Table 1, this report is being filed across two forms. This is the second of two filings.

More UTHR filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.